OQROSign up free
Insider trade

Teva Pharmaceutical Industries (TEVA): Officer sold ~$856K

Richard Daniell, Officer at Teva Pharmaceutical Industries, sold ~$856K of Teva Pharmaceutical Industries shares.

~$856K
Approx. value · 20K sh @ $42.80
56K
Holds after · shares reported
Traded
Nov 11, 2026
Filed
Nov 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 16, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  2. Oct 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 27, 2026, at a meeting of the Board of Directors (the “Board”) of Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”), the Board elected Dr. David J. Brailer to serve as a member of the Board, effective November 3, 2026, until Teva’s 2027 annual meeting of shareholders.”
  3. Nov 2, 20265% stakeHarel Insurance Investments & Financial Services Ltd. reported a passive stake (13G) of 6.0%
  4. Nov 3, 2026Company filing · Form 8-K · ResultsReported its results
  5. Nov 4, 2026Insider · 1 personInsiders: 2 sales (~$1.1M)
  6. Nov 5, 2026InsiderOfficer sold ~$1.93M of TEVA shares in the open market
  7. Nov 9, 2026Insider · 2 peopleInsiders: 4 sales (~$1.8M)
  8. Nov 10, 20265% stakeMENORA MIVTACHIM HOLDINGS LTD. reported a passive stake (13G) of 5.0%
  9. Nov 10, 2026Insider · Their largest sale since 2024CEO sold ~$10.6M of TEVA shares in the open market
  10. Nov 11, 2026 · this disclosureInsiderOfficer sold ~$856K of TEVA shares in the open market

What came next

  1. Nov 12, 2026InsiderOfficer sold ~$1.97M of TEVA shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Teva Pharmaceutical Industries

For Teva Pharmaceutical Industries, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TEVA page.

Other recent filings by Richard Daniell, EVP, Europe Commercial

The full history of Richard Daniell, EVP, Europe Commercial is on the profile page.

How this filing works

Explore the data

Other disclosures at Teva Pharmaceutical Industries

Everything OQRO holds on this company is on its TEVA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data